Topics

Samsung Bioepis Can Begin Eculizumab Trial In China

04:54 EST 15 Jan 2020 | SCRIP

Samsung Bioepis and partner AffaMed Therapeutics have received an approval from the Chinese authorities to conduct a Phase III study...

      

Related Stories

 

Original Article: Samsung Bioepis Can Begin Eculizumab Trial In China

NEXT ARTICLE

More From BioPortfolio on "Samsung Bioepis Can Begin Eculizumab Trial In China"

Quick Search

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...